Red cell distribution width is a potential predictor of early relapse in polymyalgia rheumatica
Submitted: 11 January 2021
Accepted: 15 March 2021
Published: 3 August 2021
Accepted: 15 March 2021
Abstract Views: 2671
PDF: 507
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- A. Alunno, G. Nocentini, O. Bistoni, M.G. Petrillo, E. Bartoloni Bocci, S. Ronchetti, E. Lo Vaglio, C. Riccardi, R. Gerli, Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity , Reumatismo: Vol. 64 No. 5 (2012)
- T. Aguiar, M. B. Vincent, Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor , Reumatismo: Vol. 67 No. 4 (2015)
- A. Giardina, A. Rizzo, A. Ferrante, G. Capra, G. Triolo, F. Ciccia, Giant cell arteritis associated with chronic active Epstein-Barr virus infection , Reumatismo: Vol. 65 No. 1 (2013)
- M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi, Association between red cell distribution width and response to methotrexate in rheumatoid arthritis , Reumatismo: Vol. 72 No. 1 (2020)
- D. Camellino, C. Dejaco, F. Martini, R. Cosso, G. Bianchi, Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases , Reumatismo: Early Access
- C. Manzo, M. Isetta, A. Castagna, Did the first description of patients with polymyalgia rheumatica take place in Scotland or in Denmark? , Reumatismo: Vol. 76 No. 1 (2024)
- S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri, Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center , Reumatismo: Vol. 64 No. 3 (2012)
- A. Alunno, G. Nocentini, O. Bistoni, R. Bianchini, E. Bartoloni Bocci, C. Riccardi, R. Gerli, Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR+CD25- cell subset in patients with systemic lupus erythematosus , Reumatismo: Vol. 62 No. 3 (2010)
- M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni, Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients , Reumatismo: Vol. 65 No. 6 (2013)
- S. Chandrashekara, A. Rajendran, A. Bai Jaganath, R. Krishnamurthy, Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis , Reumatismo: Vol. 67 No. 3 (2015)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.